Christine Bahls

Product liability issues can be costly to companies that aren’t prepared for them.

The two C-Path executives discuss how the organization works to translate new research into marketable treatments.

The assay, developed by Abbott Laboratories, is used to detect the hepatitis B surface antigen.

While Q2 results are still to come, investment dollars lagging far behind 2021.

O'Neill discusses the company's place in the global market and recent advancements to improve the patient experience.

Providing these recordings ensures that patients have an accurate to source to reference after a visit with a doctor.

As the pharma industry relies more and more on smart phones and other connected devices, it's important to remember that not everyone has access to this technology.

PV is on the road to becoming a leader, not a follower, in leveraging drug lifecycle information for clinical trials and to inform clinical care

Primary barriers to wholesale adoption of wearables and digital devices are lack of consistent data quality and regulatory approval.

Andrew W. Lo, PhD, a finance professor at the MIT Sloan School of Management and the director of the MIT Laboratory for Financial Engineering, discusses cultural differences between the scientific side of biopharma and the financial side.

The use of VR, AR and medically extended reality, or MXR have become more commonplace in the medical device world and in clinical practice.

A Scottish-based research group has developed a stent-graft combination for Type A dissection, which studies show greatly improved survival rate.

Non-invasive lab test 4Kscore from Opko Health, is widely available to help a patient and physician decide whether a prostate biopsy is necessary in response to an elevated PSA level, based on an algorithm developed by Memorial Sloan Kettering.

John Varaklis, chief strategy officer for PhysIQ, discusses the company's machine-learning based algorithms for the detection and early detection of physiological conditions to inform both clinical care and clinical drug development.

As a medical school and hospital system that provides clinical care on an inpatient and outpatient basis, Mount Sinai also trains medical students and graduate students. One of its goals was to enrich faculty and residency programs and train the next generation of medical scientists by bringing engineering principles to solve problems.

Ongoing efforts for standardization key in making data usable and trustworthy.

Over the past year, federal agencies, medtech associations, manufacturers and academics have been working out the steps for a predictive pathway to reimbursement that would satisfy seniors’ needs as well as the different mandates of CMS and FDA agencies.